Evidence map›Paper›PMID 37764260›Full record

ReviewMolecules (Basel, Switzerland)2023

Ultrasound Sonosensitizers for Tumor Sonodynamic Therapy and Imaging: A New Direction with Clinical Translation.

Yunlong Liang, Mingzhen Zhang, Yujie Zhang, Mingxin Zhang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Current Research in Drug-Free Cancer Therapies.Bioengineering (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yunlong LiangSecond Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
Mingzhen ZhangSchool of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.ORCID 0000-0002-4686-6526
Yujie ZhangSchool of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.ORCID 0000-0002-7969-234X
Mingxin ZhangDepartment of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.ORCID 0000-0002-3945-3387

Funding

National Natural Science Foundation of China No 82000523National Science Foundation of Shaanxi Nos. 2023-JC-QN-0817
6 · The paper itself

Abstract

With the rapid development of sonodynamic therapy (SDT), sonosensitizers have evolved from traditional treatments to comprehensive diagnostics and therapies. Sonosensitizers play a crucial role in the integration of ultrasound imaging (USI), X-ray computed tomography (CT), and magnetic resonance imaging (MRI) diagnostics while also playing a therapeutic role. This review was based on recent articles on multifunctional sonosensitizers that were used in SDT for the treatment of cancer and have the potential for clinical USI, CT, and MRI applications. Next, some of the shortcomings of the clinical examination and the results of sonosensitizers in animal imaging were described. Finally, this paper attempted to inform the future development of sonosensitizers in the field of integrative diagnostics and therapeutics and to point out current problems and prospects for their application.

Indexed as

Tomography, X-Ray ComputedAnimalsUltrasonographyclinicalintegrated diagnosis and treatmentsonodynamic therapysonosensitizers

Identifiers

PMID37764260
PMCPMC10537038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.